Europe — EMA
Odyralduo (Dorzolamide, Timolol)
Dorzolamide, the active ingredient in Odyralduo, is a carbonic anhydrase inhibitor presented as a combination formulation for ocular use.
Request sourcing
What is Dorzolamide, Timolol?
Dorzolamide, the active ingredient in Odyralduo, is a carbonic anhydrase inhibitor presented as a combination formulation for ocular use. It treats elevated intra‑ocular pressure in glaucoma patients, often in combination with a beta‑blocker. GNH USA supplies Odyralduo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Odyralduo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Dorzolamide, Timolol used for?
Odyralduo is used in the management of ocular pressure‑related conditions, primarily targeting the glaucoma disease pathway. - Primary open‑angle glaucoma: reduces intra‑ocular pressure to help preserve visual field. - Ocular hypertension: lowers eye pressure to reduce risk of progression to glaucoma. - Secondary glaucoma: assists in controlling pressure when other causes elevate intra‑ocular pressure. - Post‑surgical ocular pressure control: helps maintain target pressure after glaucoma‑related surgery.
What are the side effects of Dorzolamide, Timolol?
Common Side Effects: - Eye --- ... .... ... g - … .... ... .... … ... … ... ... ... ... ... ... ... ... - ... … .... ... ... ... … … … ... ... ... … … ... - .... … … … … … … … … … … ... … … … … …
Serious … … … … g g g - ... … g t t t t t .
- … .
What precautions apply to Dorzolamide, Timolol?
Odyral t d \\ \
